Statistics for Rockwell Medical (id:5969 RMTI)

Valuation metrics

Market cap

75.95M

Enterprise value

90.33M

Trailing P/E (ttm)

-6.30

Forward P/E

33.57

PEG ratio

33.57

Price/Sales (ttm)

0.80

Price/Book (mrq)

3.21

Enterprise Value/Revenue

0.96

Enterprise Value/EBITDA

-102.07

Overview

Shares outstanding

31.03M

Float

24.21M

Shares short

823.37K

% Held by insiders

0.12%

% Held by institutions

0.21%

Average volume (10 days)

1.83M

Average volume (90 days)

Price summary

52-Week low

1.16

52-Week high

5.15

52-Week change

21.03%

Beta

1.50

50-Day moving average

3.68

200-Day moving average

2.28

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

May 13th, 2022

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-5.06%

Operating margin

1.99%

Operational effectiveness

Return on assets

-4.25%

Return on equity

-28.90%

Income statement

Revenue (ttm)

3.04

Revenue per share (ttm)

3.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

8.70M

EBITDA

-885,000.00

Net income to common (ttm)

-4,922,000.00

Diluted EPS (ttm)

-0.15

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

11.86M

Total cash per share (mrq)

0.38

Total debt (mrq)

14.38M

Total Debt/Equity (mrq)

61.18

Current ratio (mrq)

199.80%

Book value per share (mrq)

0.73

Cash flow

Cash flow statement

-4,734,000.00

Levered free cash flow (LFCF)

-2,371,875.00